neuehealth.com (NEUE): EV/EBITDA Multiple

NeueHealth, Inc. (NEUE) - corporate logo

Amid forced asset divestitures and debt reduction efforts, NeueHealth, Inc. (NEUE) relies on an AI-powered cloud fintech service to automate settlements. This chart of the EV/EBITDA metric reflects . NeueHealth, Inc. (NEUE) integrates digital tools into medicine to create a communication system between patient and physician, optimizing healthcare costs and improving the quality of care.

NEUE NeueHealth: Enterprise Value to Operating Income Before Depreciation in the range 07/04/2022 - 11/11/2026

Metric breakdowns and analytics for neuehealth.com (NEUE)

- market price and analyst price targets:
Price Chart NeueHealth|NEUE - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Capitalization NeueHealth, Inc.|NEUE - Value Adjusted for Debt and Cash
- issuer book value statistics:
Net Assets per Single Share NeueHealth|NEUE - Accounting Capitalization|Market Capitalization to Book Value Ratio neuehealth.com|NEUE - Company Assets
- debt and solvency information:
Total Debt to Equity Ratio NeueHealth, Inc.|NEUE - Long-Term Debt to Capital|Short-Term Debt to Capital NeueHealth|NEUE - Company Cumulative Debt|Debts to Book Capitalization NeueHealth, Inc.|NEUE - Company Long-Term Loans and Borrowings|Company Short-Term Debts NeueHealth|Quick Ratio neuehealth.com
- business earnings and investment ratios data:
NEUE - Net Profit|Expected Profit NeueHealth, Inc.|NEUE - Price to Earnings Ratio|Projected Price to Earnings NeueHealth|NEUE - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple NeueHealth, Inc.|NEUE - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months NeueHealth|NEUE - Earnings per share for the trailing year|Quarterly EPS earnings growth neuehealth.com|NEUE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year NeueHealth, Inc.
Initial company analysis:NeueHealth Corp NEUE
Manufactured products of neuehealth.com

The complexity of medical legislation protects the business of NeueHealth, Inc. (NEUE) from competition, yet the current asset restructuring requires a close analysis of the company's valuation relative to its operating profit. The price action of the EV/EBITDA ratio over time demonstrates the relationship between total capital and EBITDA, allowing investors to identify asset undervaluation as the metric approaches historical lows and avoid the risk of overpaying at peaks.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization UnitedHealth Group Incorporated UNH|EV/EBITDA Multiple Cigna Health CI|Aflac - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation HUM (humana.com)|Centene (CNC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MOH|MMS (Maximus Corp) - EV/EBITDA Multiple|Company Value to EBITDA Oscar Health Corp OSCR|Enterprise Value to EBITDA Ratio CLOV (Clover Health Investments)|EV/EBITDA Multiple claritev.com (CTEV)|EV/EBITDA Multiple YB (Yuanbao)|Health In Tech Inc. (HIT) - Company Value to EBITDA|eHealth Insurance - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation GOCO (GoHealth Insurance)|RELI: EV/EBITDA Multiple|Company Value to EBITDA msprecovery.com (LIFW)|MPLN (MultiPlan) - EV/EBITDA Multiple